Lan Thi Phi
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- Cancer Cells and Metastasis
Papers in
-
- Angiogenesis and VEGF in Cancer 9
- Ginseng Biological Effects and Applications 3
- RNA Research and Splicing 2
- Genetics 11
- Mesenchymal stem cell research 11
- Co-authors
- Hyog Young Kwon (7 shared papers)Ita Novita Sari (7 shared papers)Nayoung Jun (3 shared papers)Sanghyun Lee (3 shared papers)Yinggui Yang (5 shared papers)Kwang Seock Kim (4 shared papers)Yun Kyung Lee (2 shared papers)Yoseph Toni Wijaya (5 shared papers)
- Journals
- Advances in experimental medicine and biology (2 papers)In Vitro Cellular & Developmental Biology - Animal (2 papers)Cancer Medicine (1 paper)Oncotarget (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- VietnamSouth KoreaUnited States
In The Last Decade
Lan Thi Phi
25 papers receiving 1.2k citations
Lan Thi Phi's Hit Papers
Peers
Comparison fields: 5 of 86
- Cancer Research 284
- Oncology 463
- Molecular Biology 727
- Immunology 121
- Genetics 59
Countries citing papers authored by Lan Thi Phi
This map shows the geographic impact of Lan Thi Phi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Thi Phi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Thi Phi more than expected).
Fields of papers citing papers by Lan Thi Phi
This network shows the impact of papers produced by Lan Thi Phi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Thi Phi. The network helps show where Lan Thi Phi may publish in the future.
Co-authors
The 25 scholars most cited alongside Lan Thi Phi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment Hit paper breakdown → | 2018 | 782 |
| 2 | 2018 | 165 | |
| 3 | 2018 | 36 | |
| 4 | 2016 | 35 | |
| 5 | 2018 | 33 | |
| 6 | 2016 | 24 | |
| 7 | 2018 | 23 | |
| 8 | 2020 | 23 | |
| 9 | 2019 | 22 | |
| 10 | 2021 | 21 | |
| 11 | 2017 | 16 | |
| 12 | 2016 | 12 | |
| 13 | 2017 | 9 | |
| 14 | 2016 | 8 | |
| 15 | 2016 | 7 | |
| 16 | 2017 | 6 | |
| 17 | 2014 | 6 | |
| 18 | 2017 | 5 | |
| 19 | 2014 | 5 | |
| 20 | 2016 | 4 |
About Lan Thi Phi
Lan Thi Phi is a scholar working on Molecular Biology, Genetics, Oncology, Surgery and Biomaterials, having authored 26 papers that have together received 1.3k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (11 papers), Angiogenesis and VEGF in Cancer (9 papers), Cancer Cells and Metastasis (3 papers), Electrospun Nanofibers in Biomedical Applications (3 papers), Ginseng Biological Effects and Applications (3 papers), Cancer-related molecular mechanisms research (3 papers), RNA Research and Splicing (2 papers) and Pharmacological Effects of Natural Compounds (2 papers). The work is most often cited by research in Cancer Research (284 citations), Oncology (463 citations), Molecular Biology (727 citations), Immunology (121 citations) and Genetics (59 citations). Lan Thi Phi has collaborated with scholars based in Vietnam, South Korea and United States. Frequent co-authors include Hyog Young Kwon, Ita Novita Sari, Nayoung Jun, Sanghyun Lee, Yinggui Yang, Kwang Seock Kim, Yun Kyung Lee, Yoseph Toni Wijaya, Ngoc Bich Vu and Phuc Van Pham. Their work appears in journals such as Advances in experimental medicine and biology, In Vitro Cellular & Developmental Biology - Animal, Cancer Medicine, Oncotarget and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.